TREACE MED CONCEPTS INC's ticker is TMCI and the CUSIP is 89455T109. A total of 109 filers reported holding TREACE MED CONCEPTS INC in Q4 2022. The put-call ratio across all filers is 0.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $15,652,540 | -45.4% | 1,193,939 | +6.5% | 0.94% | -39.2% |
Q2 2023 | $28,671,983 | +1.5% | 1,120,875 | 0.0% | 1.56% | -6.8% |
Q1 2023 | $28,234,841 | +29.8% | 1,120,875 | +18.5% | 1.67% | +23.8% |
Q4 2022 | $21,747,919 | +8.1% | 945,973 | +3.8% | 1.35% | +6.0% |
Q3 2022 | $20,117,000 | +50.9% | 911,509 | -2.0% | 1.27% | +64.4% |
Q2 2022 | $13,335,000 | -2.5% | 929,882 | +28.6% | 0.77% | +28.0% |
Q1 2022 | $13,676,000 | +85.9% | 723,196 | +83.2% | 0.60% | +133.2% |
Q4 2021 | $7,356,000 | +9.3% | 394,652 | +57.7% | 0.26% | +11.2% |
Q3 2021 | $6,732,000 | -13.9% | 250,247 | 0.0% | 0.23% | -9.0% |
Q2 2021 | $7,823,000 | – | 250,247 | – | 0.26% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Soleus Capital Management, L.P. | 1,907,823 | $25,011,560 | 2.31% |
FORMULA GROWTH LTD | 222,269 | $2,913,947 | 0.99% |
EMERALD MUTUAL FUND ADVISERS TRUST | 1,193,939 | $15,652,540 | 0.94% |
EMERALD ADVISERS, LLC | 1,473,281 | $19,314,713 | 0.94% |
Perceptive Advisors | 1,834,060 | $24,044,527 | 0.80% |
NEXT CENTURY GROWTH INVESTORS LLC | 512,738 | $6,721,995 | 0.73% |
OBERWEIS ASSET MANAGEMENT INC/ | 355,600 | $4,661,916 | 0.50% |
Novo Holdings A/S | 360,000 | $4,719,600 | 0.35% |
TimesSquare Capital Management, LLC | 1,433,429 | $18,792 | 0.29% |
KORNITZER CAPITAL MANAGEMENT INC /KS | 677,733 | $8,885,080 | 0.18% |